Tīmeklis2016. gada 16. febr. · Rachael Natrajan, Affiliations Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom, Division of Molecular Pathology, ... Citation: Natrajan R, Sailem H, Mardakheh FK, Arias Garcia M, Tape CJ, Dowsett M, et al. (2016) Microenvironmental Heterogeneity Parallels … TīmeklisFor her PhD, Dr Rachael Natrajan studied the molecular pathology of the paediatric kidney cancer Wilms' Tumour with Dr Chris Jones at The Institute of Cancer Research in Sutton. After this, Dr Natrajan joined the Breast Cancer Now Toby Robins Breast Cancer Research Centre as a Post-Doctoral Research Fellow, training with …
Rachel Natrajan Profiles Facebook
Tīmeklis2024. gada 31. janv. · Naomi Guppy & Rachael Natrajan. Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto, Japan. Kosuke Yusa. Authors. Sankari Nagarajan. View author publications. TīmeklisWetterskog, Magali Lacroix-Triki, Rachael Natrajan, et al. To cite this version: Konstantin J. Dedes, Maria-Angeles Lopez-Garcia, Felipe C. Geyer, Maryou B. K. Lambros, Kay Savage, et al.. Cortactin gene amplification and expression in breast cancer: a chromogenic in situ hybridisation and immunohistochemical study. jis ピクトグラム 車いす
Natrajan Semantic Scholar
TīmeklisRachael Natrajan, Ph.D. Dr. Natrajan is a team leader in the Breast Cancer Now Toby Robins Research Centre at The Institute of Cancer Research (ICR) in London, United Kingdom. Her research interests focus on understanding the progression of aggressive, therapy-resistant forms of breast cancer, with the goal of identifying novel drivers and ... Tīmeklis2024. gada 15. okt. · Dr Rachael Natrajan always knew that she wanted to pursue some kind of scientific career, but she wasn’t sure what exactly. At school, she enjoyed chemistry and biology; at university, she ... TīmeklisAberrant β-catenin expression as determined by assessment of its subcellular localization constitutes a surrogate marker of Wnt signalling pathway activation and has been reported in a subset of breast cancers. The association of β-catenin/Wnt pathway activation with clinical outcome and the mechanisms leading to its activation in breast … jis プラスチック 公差 成形